Published in Biol Reprod on June 02, 2011
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51
Perinatally administered bisphenol a as a potential mammary gland carcinogen in rats. Environ Health Perspect (2013) 1.13
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res (2012) 0.97
Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development. PLoS One (2014) 0.95
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response. Stem Cell Reports (2015) 0.93
A review of the carcinogenic potential of bisphenol A. Reprod Toxicol (2015) 0.92
High intake of dietary sugar enhances bisphenol A (BPA) disruption and reveals ribosome-mediated pathways of toxicity. Genetics (2014) 0.91
Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Reprod Toxicol (2014) 0.90
Endocrine disruption of the epigenome: a breast cancer link. Endocr Relat Cancer (2014) 0.90
Concentrations of environmental phenols and parabens in milk, urine and serum of lactating North Carolina women. Reprod Toxicol (2014) 0.87
Effects of Low-Dose Bisphenol A on DNA Damage and Proliferation of Breast Cells: The Role of c-Myc. Environ Health Perspect (2015) 0.87
Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors. J Cell Mol Med (2012) 0.83
Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity. PLoS One (2013) 0.79
Gene expression profiling analysis of bisphenol A-induced perturbation in biological processes in ER-negative HEK293 cells. PLoS One (2014) 0.79
Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay. Reprod Biol Endocrinol (2014) 0.78
Bisphenol A and hormone-associated cancers: current progress and perspectives. Medicine (Baltimore) (2015) 0.78
High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice. BMC Cancer (2015) 0.76
New insights into fetal mammary gland morphogenesis: differential effects of natural and environmental estrogens. Sci Rep (2017) 0.75
Inhalation Toxicity of Bisphenol A and Its Effect on Estrous Cycle, Spatial Learning, and Memory in Rats upon Whole-Body Exposure. Toxicol Res (2017) 0.75
Low-Dose Bisphenol A Exposure: A Seemingly Instigating Carcinogenic Effect on Breast Cancer. Adv Sci (Weinh) (2016) 0.75
The mouse mammary gland as a sentinel organ: distinguishing 'control' populations with diverse environmental histories. Environ Health (2017) 0.75
Interaction between bisphenol A and dietary sugar affects global gene transcription in Drosophila melanogaster. Genom Data (2014) 0.75
Emerging Estrogenic Pollutants in the Aquatic Environment and Breast Cancer. Genes (Basel) (2017) 0.75
Human exposure to bisphenol A (BPA). Reprod Toxicol (2007) 6.91
Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res (2006) 5.92
Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect (2002) 5.24
In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol (2007) 4.97
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology (2006) 4.22
Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev (2008) 4.03
Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Curr Biol (2003) 3.93
Stem cells and breast cancer: A field in transit. Nat Rev Cancer (2003) 3.47
Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod (2002) 3.45
A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health (1998) 3.18
In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod (2001) 2.96
An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia (2000) 2.73
Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology (2006) 2.63
Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect (2010) 2.62
Bisphenol A exposure in utero disrupts early oogenesis in the mouse. PLoS Genet (2007) 2.33
Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect (2007) 2.29
Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol (2006) 2.22
Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology (2005) 2.14
Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect (2009) 2.11
Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology (2006) 2.08
Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol (2002) 2.05
Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect (1996) 1.94
Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol (2006) 1.92
Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology (2006) 1.90
An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol (2007) 1.83
In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75
Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst (1978) 1.71
Bisphenol A levels in human urine. Environ Health Perspect (2003) 1.70
Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect (2002) 1.60
Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol (2008) 1.53
Mammary developmental fate and breast cancer risk. Endocr Relat Cancer (2005) 1.53
Environmental pollutants and breast cancer. Environ Health Perspect (2003) 1.53
Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect (2010) 1.41
Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect (2009) 1.38
Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ Health Perspect (2010) 1.32
Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol (2008) 1.31
Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect (2007) 1.28
Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol (2009) 1.25
Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol (2010) 1.24
The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue-level of organization? J Steroid Biochem Mol Biol (2006) 1.23
On the prenatal growth of the mammary gland rudiment in the mouse. J Anat (1950) 1.22
Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med (2003) 1.22
Neonatal bisphenol-a exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin-releasing hormone neurons. Biol Reprod (2009) 1.19
Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol (2008) 1.12
Bisphenol A effects on the growing mouse oocyte are influenced by diet. Biol Reprod (2009) 1.06
MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors. J Steroid Biochem Mol Biol (1993) 1.05
Persistent mammary hyperplasia in FVB/N mice. Comp Med (2003) 1.03
Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol (2005) 1.02
Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. Am J Pathol (2002) 1.02
Bisphenol A: developmental toxicity from early prenatal exposure. Birth Defects Res B Dev Reprod Toxicol (2010) 1.02
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol (2010) 0.99
Changes in reproductive organs of female rats treated with bisphenol A during the neonatal period. Reprod Toxicol (2003) 0.99
Investigations into the potential degradation of polycarbonate baby bottles during sterilization with consequent release of bisphenol A. Food Addit Contam (1997) 0.96
Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias. J Natl Cancer Inst (1976) 0.94
Biology of mammary fat pad in fetal mouse: capacity to support development of various fetal epithelia in vivo. Development (1987) 0.92
Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology (2002) 0.90
Bisphenol A induces permanent squamous change in mouse prostatic epithelium. Differentiation (2007) 0.87
Migration of bisphenol A from can coatings--effects of damage, storage conditions and heating. Food Addit Contam (2004) 0.87
Raloxifene in breast cancer prevention. Expert Opin Drug Saf (2008) 0.83
Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol (2007) 4.04
FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development (2010) 1.86
Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem (2010) 1.79
FOXA1: a transcription factor with parallel functions in development and cancer. Biosci Rep (2012) 1.52
Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genomics (2008) 1.43
Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (2011) 1.39
HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem (2010) 1.24
The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem (2012) 1.15
Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano (2012) 1.12
Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A (2011) 1.07
Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer. Mol Cancer Ther (2007) 1.05
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice. Oncogene (2005) 1.04
Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano (2012) 1.03
The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression. Mol Cancer Res (2013) 0.99
Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol (2007) 0.96
Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice. Nanomedicine (Lond) (2013) 0.92
Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology (2002) 0.90
The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc Natl Acad Sci U S A (2009) 0.88
EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer. Cancer Lett (2005) 0.83
Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells. J Pathol (2010) 0.83
Splice variants of mIAP1 have an enhanced ability to inhibit apoptosis. Biochem Biophys Res Commun (2006) 0.83
Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Res Treat (2014) 0.82
High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene. Oncogene (2003) 0.82
Ovulatory surges of human CG prevent hormone-induced granulosa cell tumor formation leading to the identification of tumor-associated changes in the transcriptome. Mol Endocrinol (2002) 0.80
FOXC1 is enriched in the mammary luminal progenitor population, but is not necessary for mouse mammary ductal morphogenesis. Biol Reprod (2013) 0.79
On-command drug release from nanochains inhibits growth of breast tumors. Pharm Res (2013) 0.79
Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Prog Horm Res (2003) 0.79
Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. Am J Physiol Endocrinol Metab (2003) 0.78
Intrinsic bias in breast cancer gene expression data sets. BMC Cancer (2009) 0.77
Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts. Biol Reprod (2012) 0.75
The pleiotropic effects of excessive luteinizing hormone secretion in transgenic mice. Semin Reprod Med (2007) 0.75